Access Safety and Efficacy Post Endovascular Intervention

NAUnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
Cardiovascular Disease.
Interventions
DEVICE

Arstasis Access System (AXERA)

Placement of the AXERA device in the Femoral Artery.

Trial Locations (17)

19713

Christiana Care, Newark

21215

Sinai Hospital, Baltimore

29169

Lexington Medical Center, West Columbia

29621

AnMed Health, Anderson

31201

Medical Center of Central Georgia, Macon

35801

Heart Center Research, LLC, Huntsville

38801

Northern Mississippi Medical Center, Tupelo

39401

Hattiesburg Clinic, Hattiesburg

70570

Opelousas General Health System, Opelousas

72211

Arkansas Heart Hospital, Little Rock

74104

St. John Medical Center, Tulsa

89113

St. Rose Dominican, Las Vegas

92037

Scripps Green, La Jolla

92354

Loma Linda University Health, Loma Linda

95204

St. Joseph's Medical Center, Stockton

95816

Mercy Heart and Vascular Institute, Sacramento

98405

Franciscan Research Center, Tacoma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Arstasis, Inc.

INDUSTRY

NCT01773148 - Access Safety and Efficacy Post Endovascular Intervention | Biotech Hunter | Biotech Hunter